Shimadzu Assumes Responsibilities for X-ray Spectrometer Business
News Mar 07, 2007
Shimadzu Scientific Instruments, Inc. (SSI) has announced the transfer of the X-ray spectrometer business from Kratos Analytical, a wholly owned subsidiary of Shimadzu Corporation, to SSI.
Effective April 1, SSI will handle sales, service, and technical support for current and future customers of Shimadzu’s X-ray spectrometers in the United States, Canada, and Mexico.
Product groups involved in this transfer include the Energy Dispersive X-ray (EDX) Series, the X-ray Diffraction (XRD) Series, and the Wavelength Dispersive X-Ray (WD-XRF) Series. A main focus for SSI will be the bench-top EDX-720, which combines the latest high count-rate electronics with intelligent software that stops measurements when the signal reaches the proper statistical threshold.
The EDX-720 is equipped with new, specialized filters and enables users to perform analysis at parts-per-million (ppm) levels without sample pretreatment. At this level of performance the EDX-720 can be used for regulatory compliance (e.g. RoHS and ELV) and/or quantitative analysis and monitoring processes.
“Acquiring the X-ray business further enhances our spectroscopy product line, giving customers a wider range of solutions to address their application requirements,” stated Bob Clifford, PhD, Product Manager.
“In particular, for those companies addressing RoHS and other regulatory requirements, the addition of the EDX provides companies with a single-source instrument supplier to meet their screening and quantitative requirements,” Clifford added.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE